Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes
- PMID: 22011484
- PMCID: PMC3214410
- DOI: 10.4103/0301-4738.86306
Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes
Abstract
Aim: The aim was to study the structural sequelae and refractive outcome after laser treatment for Type 1 prethreshold retinopathy of prematurity (ROP) in Asian Indian eyes.
Materials and methods: A retrospective chart review of infants with Type 1 prethreshold ROP (defined according to the Early Treatment for Retinopathy of Prematurity study) undergoing laser treatment at a tertiary center between January 2004 and December 2008 was done. The 1-year outcome of infants was analyzed.
Results: Sixty-nine eyes of 36 infants were included. The mean birth weight was 1121.69 ± 254.81 g and the gestational age was 28.99 ± 2.03 weeks. Sixty-five eyes (94.2%) had zone 2 and 4 (5.8%) had zone 1 disease. Forty-four (63.77%) eyes had stage 2 ROP with plus disease and 25 (36.23%) eyes had prethreshold (fewer than five contiguous or eight cumulative clock hours) stage 3 ROP with plus disease. None of the eyes developed retinal structural sequelae. On cycloplegic retinoscopy, 59.4% eyes had nonsignificant hyperopia [spherical equivalent (SE) ≤ 4 D], 14.5% eyes had no refractive error (SE 0 D), 24.7% eyes had low myopia (SE < 5 D), and 1.4% eyes had high myopia (SE > 5.0 D). Eyes developing myopia were associated with a greater number of clock hours of ROP, greater number of laser spots used, and a longer time to disease regression . Two infants (5.6%) had esotropia and one (2.8%) had exotropia.
Conclusion: Asian Indian infants treated for Type 1 prethreshold ROP did not develop retinal structural sequelae. Myopia was seen in nearly one-fourth of the eyes.The risk factors for myopia were a greater number of clock hours of ROP, greater number of laser spots, and a longer time to regression of ROP.
Conflict of interest statement
Comment in
-
Nanotechnology in ophthalmology.Indian J Ophthalmol. 2013 May;61(5):244-5. doi: 10.4103/0301-4738.97557. Indian J Ophthalmol. 2013. PMID: 23552352 Free PMC article. No abstract available.
Similar articles
-
Prevalence of myopia at 9 months in infants with high-risk prethreshold retinopathy of prematurity.Ophthalmology. 2005 Sep;112(9):1564-8. doi: 10.1016/j.ophtha.2005.03.025. Ophthalmology. 2005. PMID: 16023214 Clinical Trial.
-
Refractive Changes among Diode Laser-treated Retinopathy of Prematurity Patients: A Retrospective Study.Middle East Afr J Ophthalmol. 2024 Jan 22;30(1):37-43. doi: 10.4103/meajo.meajo_117_23. eCollection 2023 Jan-Mar. Middle East Afr J Ophthalmol. 2024. PMID: 38435111 Free PMC article.
-
Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age.Ophthalmology. 2008 Jun;115(6):1058-1064.e1. doi: 10.1016/j.ophtha.2007.07.028. Ophthalmology. 2008. PMID: 18423871 Clinical Trial.
-
Refractive status, biometric components, and functional outcomes of patients with threshold retinopathy of prematurity: systemic review and a 17-year longitudinal study.Graefes Arch Clin Exp Ophthalmol. 2022 Dec;260(12):3809-3816. doi: 10.1007/s00417-022-05730-6. Epub 2022 Jun 22. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35729410
-
Laser treatment for retinopathy of prematurity.Lasers Med Sci. 2013 Feb;28(2):683-92. doi: 10.1007/s10103-011-1021-z. Epub 2011 Dec 2. Lasers Med Sci. 2013. PMID: 22134790 Review.
Cited by
-
One-year refractive outcomes after intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity.Int Ophthalmol. 2023 Jul;43(7):2197-2202. doi: 10.1007/s10792-022-02615-9. Epub 2022 Dec 15. Int Ophthalmol. 2023. PMID: 36522564
-
One-year clinical outcome after laser treatment for retinopathy of prematurity at a tertiary center in Turkey.Int Ophthalmol. 2015 Feb;35(1):27-35. doi: 10.1007/s10792-014-0014-x. Epub 2014 Nov 9. Int Ophthalmol. 2015. PMID: 25381161
-
Outcomes of early versus deferred laser after intravitreal ranibizumab in aggressive posterior retinopathy of prematurity.Indian J Ophthalmol. 2021 Aug;69(8):2171-2176. doi: 10.4103/ijo.IJO_3016_20. Indian J Ophthalmol. 2021. PMID: 34304203 Free PMC article. Clinical Trial.
-
Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?Int Ophthalmol. 2023 May;43(5):1453-1458. doi: 10.1007/s10792-022-02540-x. Epub 2022 Sep 23. Int Ophthalmol. 2023. PMID: 36149616
-
Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity.Indian J Ophthalmol. 2017 Sep;65(9):835-840. doi: 10.4103/ijo.IJO_872_16. Indian J Ophthalmol. 2017. PMID: 28905827 Free PMC article.
References
-
- Palmer EA, Flynn JT, Hardy RJ, Phleps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of Prematurity. Ophthalmology. 1991;11:1628–40. - PubMed
-
- Kinsey VE, Arnold HJ, Kalina RE, Stern L, Stahlman M, Odell G, et al. PaO2 levels and retrolental fibroplasia: A report of the cooperative study. Pediatrics. 1977;60:655–68. - PubMed
-
- Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: Three month outcome. Arch Ophthalmol. 1990;108:195–204. - PubMed
-
- Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: One year outcome, structure and function. Arch Ophthalmol. 1990;108:1408–16. - PubMed
-
- Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. 3 1/2-year outcome, structure and function. Arch Ophthalmol. 1993;111:339–44. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical